Accès ouvert
2026
dataset
OpenAlex
Inès Rezzoug, Océane Vanparis, Joséphine Poiraud, Subidsha Nandakumaran et autres
This study analysed a large French collection of carbapenemase-producing Klebsiella oxytoca complex (KoC) isolates (2017–2023) to map species and carbapenemase distributions and identify emerging lineages. We further investigated virulence traits to understand the epidemiological success of the dominant ST-2 lineage. We conducted …
Accès ouvert
2026
dataset
OpenAlex
Inès Rezzoug, Océane Vanparis, Joséphine Poiraud, Subidsha Nandakumaran et autres
This study analysed a large French collection of carbapenemase-producing Klebsiella oxytoca complex (KoC) isolates (2017–2023) to map species and carbapenemase distributions and identify emerging lineages. We further investigated virulence traits to understand the epidemiological success of the dominant ST-2 lineage. We conducted …
Accès ouvert
2026
dataset
OpenAlex
Inès Rezzoug, Océane Vanparis, Joséphine Poiraud, Subidsha Nandakumaran et autres
This study analysed a large French collection of carbapenemase-producing Klebsiella oxytoca complex (KoC) isolates (2017–2023) to map species and carbapenemase distributions and identify emerging lineages. We further investigated virulence traits to understand the epidemiological success of the dominant ST-2 lineage. We conducted …
Accès ouvert
2026
dataset
OpenAlex
Laurent Dortet, Charlotte Moreau, Aurélien Dinh, Rémy A. Bonnin et autres
OXA-48–producing Enterobacterales (OXA-48-PE) represent a growing global health threat. Most of OXA-48–PE remain categorized susceptible to carbapenems, which might encourage their use despite uncertain clinical efficacy. This study evaluated clinical outcomes of infections caused by OXA-48-PE treated with carbapenem compared with alternative …
Accès ouvert
2026
dataset
OpenAlex
Laurent Dortet, Charlotte Moreau, Aurélien Dinh, Rémy A. Bonnin et autres
OXA-48–producing Enterobacterales (OXA-48-PE) represent a growing global health threat. Most of OXA-48–PE remain categorized susceptible to carbapenems, which might encourage their use despite uncertain clinical efficacy. This study evaluated clinical outcomes of infections caused by OXA-48-PE treated with carbapenem compared with alternative …